Claret Asset Management’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,020
Closed -$98K 354
2024
Q2
$98K Sell
15,020
-54,168
-78% -$408K 0.02% 248
2024
Q1
$652K Sell
69,188
-5,793
-8% -$49.6K 0.11% 88
2023
Q4
$592K Buy
74,981
+30
+0% +$218 0.11% 87
2023
Q3
$503K Buy
74,951
+37,240
+99% +$305K 0.1% 88
2023
Q2
$369K Buy
+37,711
New +$383K 0.07% 104
2021
Q2
Sell
-37,821
Closed -$385K 208
2021
Q1
$385K Buy
37,821
+2,923
+8% +$27.5K 0.07% 123
2020
Q4
$273K Sell
34,898
-1,144
-3% -$10.1K 0.05% 141
2020
Q3
$313K Sell
36,042
-156,247
-81% -$1.58M 0.07% 132
2020
Q2
$1.84M Sell
192,289
-1,966,105
-91% -$15.3M 0.44% 47
2020
Q1
$10.1M Sell
2,158,394
-230,805
-10% -$1.14M 2.86% 10
2019
Q4
$15M Sell
2,389,199
-68,946
-3% -$478K 2.87% 8
2019
Q3
$17M Buy
+2,458,145
New +$16.4M 3.49% 4

Other funds holding VMD

Claret Asset Management's VMD Position: Q3 2024 in Review

Claret Asset Management sold out of Viemed Healthcare (VMD) in Q3 2024, closing a stake of 15,020 shares — an estimated $98K sold.

Claret Asset Management first reported a position in VMD in Q3 2019 and held it in 12 quarters. The position peaked at $17M in Q3 2019. 121 funds tracked by Wall St. Rank hold VMD as of Q3 2024.

  • Claret Asset Management reported no remaining Viemed Healthcare position as of Q3 2024 after selling out during the quarter.
  • Claret Asset Management sold 15,020 Viemed Healthcare shares in Q3 2024, an estimated $98K.
  • Claret Asset Management first reported a position in Viemed Healthcare in Q3 2019 and held it in 12 quarters.
  • Claret Asset Management's Viemed Healthcare position peaked at $17M in Q3 2019.
  • 121 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2024.

Based on Claret Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.